Test Code MAGU Magnesium, 24 Hour, Urine
Useful For
Assessing the cause of abnormal serum magnesium concentrations using a 24-hour urine collection
Determining whether nutritional magnesium loads are adequate
Calculating urinary calcium oxalate and calcium phosphate supersaturation and assessing kidney stone risk
Special Instructions
Method Name
Colorimetric Endpoint Assay
Reporting Name
Magnesium, 24 HR, USpecimen Type
UrineNecessary Information
Specimen volume in milliliters and duration are required.
Specimen Required
Supplies: Sarstedt 5 mL Aliquot Tube (T914)
Collection Container/Tube: 24-hour graduated urine container with no metal cap or glued insert
Submission Container/Tube: Plastic, 5 mL tube or a clean, plastic urine container with no metal cap or glued insert
Specimen Volume: 4 mL
Collection Instructions:
1. Collect urine for 24 hours.
2. Refrigerate specimen within 4 hours of completion of 24-hour collection.
Additional Information: See Urine Preservatives-Collection and Transportation for 24-Hour Urine Specimens for multiple collections.
Specimen Minimum Volume
1 mL
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Urine | Refrigerated (preferred) | 14 days | |
Frozen | 30 days | ||
Ambient | 72 hours |
Reject Due To
All specimens will be evaluated at Mayo Clinic Laboratories for test suitability. |
Clinical Information
Magnesium, along with potassium, is a major intracellular cation. Magnesium is a cofactor of many enzyme systems. All adenosine triphosphate-dependent enzymatic reactions require magnesium as a cofactor. Approximately 70% of magnesium ions are stored in bone. The remainder are involved in intermediary metabolic processes; about 70% are present in free form, while the other 30% are bound to proteins (especially albumin), citrates, phosphate, and other complex formers. The serum magnesium level is kept constant within very narrow limits
Renal handling of magnesium is determined by the combination of filtration and reabsorption. Roughly 70% of the magnesium in plasma is filtered by the glomeruli; 20% to 30% of the filtered magnesium is reabsorbed in the proximal tubule, while less than 5% is reabsorbed in the distal tubule and collecting duct.(1)
Numerous causes of renal magnesium wasting have been identified including (but not limited to) congenital defects (including Barter and Gitelman syndrome), various endocrine disorders (including hyperaldosteronism and hyperparathyroidism), exposure to certain drugs (ie, diuretics, cis-platinum, aminoglycoside antibiotics, calcineurin inhibitors), and other miscellaneous causes (including chronic alcohol abuse). Gastrointestinal conditions associated with fat malabsorption and chronic diarrhea can cause fecal magnesium loss and hypomagnesemia. High levels of plasma magnesium are typically only seen in patients with decreased renal function, after administration of a magnesium load large enough to exceed the kidneys' ability to excrete it, or a combination of the 2.(2)
Magnesium is an inhibitor of calcium crystal growth and contributes to urinary calcium oxalate and calcium phosphate supersaturation. However, low urinary magnesium in isolation has not been identified as a common cause of kidney stones, nor has magnesium supplementation been proven as an effective therapy for stone prevention.
Reference Values
51-269 mg/24 hours
Reference values have not been established for patients <18 years and >83 years of age.
Interpretation
Urinary magnesium excretion should be interpreted in concert with serum concentrations.
In the presence of hypomagnesemia, a 24-hour urine magnesium greater than 24 mg/day or fractional excretion greater than 0.5% suggests renal magnesium wasting. Lower values suggest inadequate magnesium intake and/or gastrointestinal losses.
In the presence of hypermagnesemia, urinary magnesium levels provide an indication of current magnesium intake.
Lower urinary magnesium excretion increases urinary calcium oxalate and calcium phosphate supersaturation and could contribute to kidney stone risk.
Cautions
Urinary magnesium excretion must be interpreted with caution during periods of intravenous magnesium infusion.
Method Description
In alkaline solution, magnesium forms a purple complex with xylidyl blue, diazonium salt. The magnesium concentration is measured photometrically via the decrease in xylidyl blue absorbance.(Package insert: Roche MG2 kit. Roche Diagnostics;Â V8.0 01/2020)
Performing Laboratory
Mayo Clinic Laboratories in RochesterTest Classification
This test has been cleared, approved, or is exempt by the US Food and Drug Administration and is used per manufacturer's instructions. Performance characteristics were verified by Mayo Clinic in a manner consistent with CLIA requirements.CPT Code Information
83735
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
MAGU | Magnesium, 24 HR, U | 24447-5 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
MG24 | Magnesium, 24 HR, U | 24447-5 |
TM115 | Collection Duration | 13362-9 |
VL111 | Urine Volume | 3167-4 |
Day(s) Performed
Monday through Sunday